# Guaifenesin and Pseudoephedrine Hydrochloride

NDC: 0363-0077
Generic name: Guaifenesin and Pseudoephedrine Hydrochloride
Labeler / Manufacturer: WALGREEN COMPANY
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20170801

FDA application: NDA021585

## Active ingredients

- GUAIFENESIN: 600 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0363-0077"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0363-0077
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=310d14be-e7ea-44b8-8b04-cffa39440d50
